| Literature DB >> 18941205 |
Kerstin A Sauer1, Joachim H Maxeiner, Roman Karwot, Petra Scholtes, Hans A Lehr, Mark Birkenbach, Richard S Blumberg, Susetta Finotto.
Abstract
EBV-induced gene 3 (EBI-3) codes for a soluble type I receptor homologous to the p40 subunit of IL-12 that is expressed by APCs following activation. In this study, we assessed the role of EBI-3 in a model of lung melanoma metastasis. Intravenous injection of the B16-F10 cell line resulted in a significant reduction of lung tumor metastasis in EBI-3(-/-) recipient mice compared with wild-type mice. The immunological finding accompanying this effect was the expansion of a newly described cell subset called IFN-gamma producing killer dendritic cells associated with CD8(+) T cell responses in the lung of EBI-3(-/-) mice including IFN-gamma release and TNF-alpha-induced programmed tumor cell death. Depletion of CD8(+) T cells as well as targeting T-bet abrogated the protective effects of EBI-3 deficiency on lung melanoma metastases. Finally, adoptive transfer of EBI-3(-/-) CD8(+) T cells into tumor bearing wild-type mice inhibited lung metastasis in recipient mice. Taken together, these data demonstrate that targeting EBI-3 leads to a T-bet-mediated antitumor CD8(+) T cell responses in the lung.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18941205 PMCID: PMC3996841 DOI: 10.4049/jimmunol.181.9.6148
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422